News

ESC presents preliminary results of Atrial Fibrillation General Registry Results for a pilot registry on the management and treatment of atrial fibrillation (AF) in Europe were presented by the European Society of Cardiology (ESC). AF is the...

RIDGEWOOD, NJ, December 16, 2013 — To effectively treat heart rhythm abnormalities, you first have to identify the source of the problem. The Valley Hospital in Ridgewood, NJ, is the first hospital in the country to employ a revolutionary 3-D...

Boston Scientific Corporation has received CE Mark approval of its X4 line of quadripolar CRT-D systems, including the AUTOGEN™ X4, DYNAGEN™ X4, and INOGEN™ X4 cardiac resynchronization therapy defibrillators (CRT-Ds), a suite of ACUITY™ X4...

St. Paul’s Hospital became the first hospital in North America to trial a unique radiation protection technology for physicians and hospital staff who perform interventional cardiovascular procedures. Dr. Andrew Krahn, Head of the Division...

The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably by a majority, Yes: 13, No: 1, that the benefits of the WATCHMAN Left Atrial Appendage Closure device...

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced that the INTENSIA family of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT-D) devices...

Arrhythmia and Electrophysiology Review has published an article that reviews the importance of the Convergent Procedure in addressing the large patient population suffering from persistent and longstanding persistent atrial fibrillation...

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that the Company’s GencaroTM Investigational New Drug (IND) application for atrial...

For two years, entrepreneur and recreational hockey player Deron Siddons was unable to take to the ice, and even considered quitting his job, because an arrhythmia called atrial fibrillation caused his heart to beat erratically for up to 48...

HeartWare International, Inc. (Nasdaq: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has acquired...